UCLA Researchers & Innovators
Industry & Investors
News & Events
About
Concierge
Search Results - stuart+conway
3
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
A Novel Chemical Modification of PROTACs (Proteolysis Targeting Chimeras) to Increase Selectivity in Hypoxic Environments (UCLA Case No. 2024-094)
UCLA researchers from the Department of Chemistry and Biochemistry have developed a novel chemical modification of PROTACs to increase their selectivity under hypoxic conditions. BACKGROUND: Proteolysis targeting chimeras (PROTACs) are molecules that induce targeted degradation of proteins by recruiting a ubiquitin ligase to a protein of interest...
Published: 3/18/2026
|
Inventor(s):
Stuart Conway
Keywords(s):
Category(s):
Chemical > Synthesis
,
Therapeutics > Oncology
Targeted Protein Degradation in Cancer via Hypoxia-Activated PROTACs and Molecular Glues (UCLA Case No. 2024-095)
UCLA researchers from the Department of Molecular and Medical Pharmacology have developed a dual small-molecule platform for targeted protein degradation in cancer. By combining hypoxia-activated PROTACs with rationally designed molecular glues, this approach addresses key limitations in tumor selectivity. BACKGROUND: Despite major advances in cancer...
Published: 3/18/2026
|
Inventor(s):
Stuart Conway
Keywords(s):
Category(s):
Therapeutics > Oncology
,
Therapeutics > Oncology > Oncology (Small Molecules)
Analoging and SAR-Based Chemical Approach to Improve the Therapeutic Potency of Small-Molecule Inhibitors of Metastasis (UCLA Case No. 2024-116)
UCLA researchers in the Department of Molecular and Medical Pharmacology have developed an analoging and SAR-based chemical approach to generate novel, safe, and effective small-molecule inhibitors for preventing and treating cancer metastasis. BACKGROUND: The limited understanding of the biological mechanisms underlying metastasis in clear cell renal...
Published: 9/19/2025
|
Inventor(s):
Lily Wu
,
Moe Ishihara
,
Robert Damoiseaux
,
Stuart Conway
Keywords(s):
Cancer
,
Metastasis
,
Oncology (Small Molecules, Peptides and Antibodies)
,
Small molecule therapeutics
,
small molecules
Category(s):
Therapeutics > Oncology